- Patients
- Clinical Research
- Clinical trials
- ANZadapt
2024-06-12T10:49:29.373Z
ANZadapt
ANZadapt
Prostate cancer
A Phase II Randomised Controlled Trial of Patient-specific Adaptive vs. Continuous Abiraterone or eNZalutamide in mCRPC (ANZadapt)
A Phase II Randomised Controlled Trial of Patient-specific Adaptive vs. Continuous Abiraterone or eNZalutamide in mCRPC (ANZadapt)
Trial overview
Clinical Area
Medical Oncology
Disease / Condition
Prostate
Study Phase
II
Trial Identifiers
Registration number: NCT05393791
GenesisCare Location(s)
GenesisCare North Shore
GenesisCare North Shore
:::
Principal Investigator(s)